Links and risks associated with psoriasis and metabolic syndrome
- PMID: 29387589
- PMCID: PMC5683108
- DOI: 10.2147/PTT.S54089
Links and risks associated with psoriasis and metabolic syndrome
Abstract
Introduction: Psoriasis has long been considered a systemic inflammatory disease. Lately, it has been strongly associated with obesity, as well as other components of metabolic syndrome, such as dyslipidemia, insulin resistance, and arterial hypertension.
Methods: We reviewed the literature of the last decade by using the keywords: psoriasis, metabolic syndrome, and/or obesity in PubMed and Medline.
Results: Obesity and psoriasis seem to share similar profiles of systemic inflammation. Serum cytokines such as TNF-α, CRP, IL-6, and IL-12 are elevated in both disorders. The more severely an individual is affected with psoriasis, the more likely it is to be obese. This makes the disease an important health care issue, which requires the cooperation of dermatologists with other medical specialists.
Discussion: This review attempts to summarize the links and risks that associate psoriasis with obesity, and highlight the concerns and queries for both disorders in the future.
Keywords: inflammation; metabolic; obesity; psoriasis; syndrome.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.Br J Dermatol. 2007 Oct;157(4):649-55. doi: 10.1111/j.1365-2133.2007.08068.x. Epub 2007 Jul 11. Br J Dermatol. 2007. PMID: 17627791 Review.
-
[Metabolic disorders in patients with psoriasis].Przegl Lek. 2011;68(12):1193-8. Przegl Lek. 2011. PMID: 22519279 Review. Polish.
-
Compounds of psoriasis with obesity and overweight.Postepy Hig Med Dosw (Online). 2017 Aug 24;71(1):761-772. doi: 10.5604/01.3001.0010.3854. Postepy Hig Med Dosw (Online). 2017. PMID: 28894050 Review.
-
Psoriasis and the metabolic syndrome.J Drugs Dermatol. 2008 Jun;7(6):563-72. J Drugs Dermatol. 2008. PMID: 18561588 Review.
-
A Holistic View of Psoriasis: Examining Its Association With Dyslipidemia and Obesity in a Decade-Long Systematic Review and Meta-Analysis.Cureus. 2023 Nov 22;15(11):e49241. doi: 10.7759/cureus.49241. eCollection 2023 Nov. Cureus. 2023. PMID: 38143612 Free PMC article. Review.
Cited by
-
Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases.Nutrients. 2025 Apr 3;17(7):1253. doi: 10.3390/nu17071253. Nutrients. 2025. PMID: 40219010 Free PMC article. Review.
-
Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis.Ann Dermatol. 2022 Aug;34(4):253-260. doi: 10.5021/ad.21.100. Ann Dermatol. 2022. PMID: 35948327 Free PMC article.
-
Association between physical activity and risk of prevalent psoriasis: A MOOSE-compliant meta-analysis.Medicine (Baltimore). 2018 Jul;97(27):e11394. doi: 10.1097/MD.0000000000011394. Medicine (Baltimore). 2018. PMID: 29979432 Free PMC article.
-
Metabolic syndrome may be more frequent in treatment-naive sarcoidosis patients.Z Rheumatol. 2024 Feb;83(Suppl 1):154-159. doi: 10.1007/s00393-022-01210-8. Epub 2022 Apr 26. Z Rheumatol. 2024. PMID: 35471670 English.
-
MiR-126 correlates with increased disease severity and promotes keratinocytes proliferation and inflammation while suppresses cells' apoptosis in psoriasis.J Clin Lab Anal. 2018 Nov;32(9):e22588. doi: 10.1002/jcla.22588. Epub 2018 Jun 26. J Clin Lab Anal. 2018. PMID: 29943471 Free PMC article.
References
-
- Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995;32(6):982–986. - PubMed
-
- Krueger GG, Papp KA, Stough DB, et al. A randomized, double-blind, placebo controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol. 2002;47(6):821–833. - PubMed
-
- Mease PJ, Goffe BS, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet. 2000;356(9227):385–390. - PubMed
-
- Shirai K. Obesity as the core of the metabolic syndrome and the management of coronary heart disease. Curr Med Res Opin. 2004;20(3):295–304. - PubMed
-
- Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control study. J Invest Dermatol. 2005;125(1):61–67. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous